Skip to main content

Year: 2025

Davis Commodities Evaluates China & North Asia Scale-Up Strategy in Multi-Billion-Dollar Sweeteners Market

SINGAPORE, Dec. 29, 2025 (GLOBE NEWSWIRE) — Davis Commodities Limited (“Davis Commodities” or the “Company”) announced that it is evaluating a strategic scale-up framework for China and North Asia, supported by the assessment of sugar-based, value-added sweeteners positioned for expanding consumption channels and industrial food applications. This initiative forms part of the Company’s ongoing review of potential downstream integration opportunities, regional diversification strategies, and pathways to build scalable, higher-value growth platforms. Positioning Toward a Multi-Billion-Dollar Demand Environment China and broader North Asia continue to represent one of the world’s most active sweetener consumption ecosystems, supported by: •Expanding middle-class consumption patterns•Growth in beverage and packaged-food innovation...

Continue reading

WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026

Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) — WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd. (“Hunan Saitumofei”) has entered into a one-year exclusive distribution agreement (the “Agreement”) with Shanghai Benke Medical Technology Co., Ltd. (“Shanghai Benke”) to promote and distribute its newly launched AI-Automated Blood Cell Morphology Analyzer (CM-B600) (the “Analyzer”) in East China throughout 2026. The collaboration is expected to accelerate market access and drive large-scale commercialization of the new product. Pursuant to the Agreement,...

Continue reading

XBP Global Partners with a Leading Property and Casualty Insurance Organization to Transform Payment Processing Through AI-Driven Automation

IRVING, Texas, Dec. 29, 2025 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a workflow automation leader that leverages decades of industry experience, a global footprint, and agentic AI to rethink business process automation and digital transformation, announced a strategic, multi-year partnership with a leading U.S. based property and casualty (P&C) insurance provider. The engagement, valued at approximately $24 million over five years, will modernize the insurer’s payment ecosystem through XBP’s intelligent, automation solutions. As part of the partnership, XBP will deploy its advanced AI-driven and RPA-infused automation platform to digitize and streamline end-to-end payment operations specifically designed for the P&C insurance processing. A key component of this transformation...

Continue reading

Charging Robotics: Revoltz Successfully Demonstrates PORTO Micro-EV to an Israeli Government Entity for Potential Urban Applications

Tel Aviv, Israel, Dec. 29, 2025 (GLOBE NEWSWIRE) — Charging Robotics Inc. (OTC: CHEV), today announced that its subsidiary, Revoltz Ltd. (of which Charging Robotics owns 51.07%), has successfully presented and demonstrated its flagship PORTO electric micro-mobility vehicle to representatives of an Israeli government entity The demonstration highlights the PORTO’s potential to transform last-mile delivery operations in urban environments with efficient, sustainable, and agile transportation. Revoltz, specializing in high-end mini electric vehicles that bridge traditional automotive design with innovative micro-mobility solutions, showcased the PORTO – a compact, three-wheeled electric cargo vehicle engineered specifically for last-mile logistics. Key features of the PORTO include:Exceptional cargo capacity comparable to...

Continue reading

Apranga Group investor’s calendar for the year 2026

The expected company releases and investor news of Apranga Group in 2026 will be announced as follows: 05.01.2026 – Retail turnover in December 202502.02.2026 – Retail turnover in January 202627.02.2026 – Interim information for 12 months 202502.03.2026 – Retail turnover in February 202601.04.2026 – Retail turnover in March 202603.04.2026 – Notice on General shareholders’ meeting29.04.2026 – Interim information for 3 months 202630.04.2026 – General shareholders’ meeting30.04.2026 – Annual information for 202502.05.2026 – Retail turnover in April 202602.06.2026 – Retail turnover in May 202601.07.2026 – Retail turnover in June 202629.07.2026 – Interim report for 6 months 202601.08.2026 – Retail turnover in July 202601.09.2026 – Retail turnover in August...

Continue reading

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe Nutriband Inc. Shareholders will retain 10% of the shareholding in Earth Vision Bio following the acquisition The expected closing date for the transaction is Dec 31, 2025. ORLANDO, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that it has signed an agreement to sell a 90% interest in its subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio. Earthvision Bio has developed and are commercializing a new category of sustainable products created by Dr. Gordon Moore, the founder of Intel (NASDAQ: INTC), and Dr. Hans Franke, who was board chairman for Chevron Europe. The Company...

Continue reading

ECD Automotive Design Launches Luxury Agent Program to Expand Sales Reach and Drive Production Growth

New Sales Channel Builds on 2026 Product Expansion and Advances Factory Utilization Strategy KISSIMMEE, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (“ECD” or the “Company”) (NASDAQ: ECDA), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs, and Toyota FJs, today announced the launch of its Luxury Agent Program, a new sales channel designed to complement the Company’s existing direct-to-consumer strategy, expand market reach, and increase production. Under the Luxury Agent Program, ECD will partner with select U.S.-based luxury and exotic automotive advisors, including dealers and professionals (the “Luxury Agents”) deeply embedded in the high-net-worth and collector vehicle ecosystem. These...

Continue reading

iPower Completes Initial Digital Asset Treasury Purchases

RANCHO CUCAMONGA, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”) today announced that it has completed its initial acquisitions under its Digital Asset Treasury (“DAT”) strategy, marking the Company’s first deployment of capital into digital assets. On Friday, December 26, 2025, through a subsidiary account maintained at BitGo, iPower executed the following transactions as part of its DAT strategy:Purchased 15.1 Bitcoin (BTC) at an average price of $87,686.33 per BTC, for a total notional value of approximately $1,325,400; and Purchased 301.1 Ethereum (ETH) at an average price of $2,934.67 per ETH, for a total notional value of approximately $883,600.“We view this initial deployment as an important milestone in executing our broader crypto strategy,” said Lawrence Tan, CEO of...

Continue reading

Clean Energy Technologies Affiliate Vermont Renewable Gas Advances Regulatory Review

IRVINE, CA., Dec. 29, 2025 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (“CETY” or the “Company”), a clean energy technology company delivering scalable solutions in power generation, storage, waste-to-energy, and heat-to-power, today announced that Vermont Renewable Gas, LLC (“VRG”), a CETY affiliate, has submitted its first round of discovery responses in the Vermont Public Utility Commission’s Certificate of Public Good (CPG) review process for its proposed 2.2 MW renewable electric generation facility in Lyndon, Vermont. The submission represents a routine and collaborative step in Vermont’s established regulatory framework and reflects continued engagement with state agencies involved in the review process, including the Vermont Public Utility Commission, the Agency of Natural Resources, the Department...

Continue reading

Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026

Mission-aligned community focused on accelerating breakthroughs in Alzheimer’s disease, Parkinson’s disease and related conditions Supported by Health Moonshot Champions, including the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures Apollo House, the Founders & Funders Networking Summit, to bring together founders, funders and industry leaders addressing Health Moonshots worldwide Longeveron will also be hosting meetings with institutional investors and potential partners during the weekMIAMI, Dec. 29, 2025 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that, as a StartUp Health Alzheimer’s & Brain Health Moonshot company, it will be participating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.